ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM) — FDA Approval ANDA213859 (GUANGZHOU NOVAKEN)
ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM) — FDA Approval ANDA213859 (GUANGZHOU NOVAKEN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ESOMEPRAZOLE MAGNESIUM; Active ingredients: ESOMEPRAZOLE MAGNESIUM; Application number: ANDA213859.
| Brand name | ESOMEPRAZOLE MAGNESIUM |
|---|---|
| Active ingredients | ESOMEPRAZOLE MAGNESIUM |
| Application number | ANDA213859 |
| Sponsor | GUANGZHOU NOVAKEN |
| Dosage form | CAPSULE, DELAYED REL PELLETS |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20201118 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →